Latest News about AMGN
Recent news which mentions AMGN
From Benzinga
From Benzinga
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
July 28, 2023
From Benzinga
From Motley Fool
AbbVie's Skyrizi Achieves Superiority Versus Amgen's Drug In Head-to-Head Study In Moderate Plaque Psoriasis
July 26, 2023
From Benzinga
Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries
July 26, 2023
From Benzinga
2 Cheap High-Yield Dividend Stocks to Buy Now
July 25, 2023
From Motley Fool
From InvestorPlace
Johnson & Johnson’s stock jumps after earnings top estimates and company raises guidance
July 20, 2023
From MarketWatch
Tesla On Tap: "Mega-cap" Reporting Season Gets Underway After Close With EV Giant's Earnings
July 19, 2023
From Benzinga
Softbank, Amgen-Backed Neumora Therapeutics Unveils Plans For Three Phase 3 Studies For Major Depressive Disorder
July 18, 2023
From Benzinga
3 Biotech Stocks for Getting Rich in 2023
July 18, 2023
From InvestorPlace
Venturing Beyond The Magic Kingdom: Former Disney CFO And Fortune 500 Veteran Takes The Reins At Lucy Scientific
July 14, 2023
From Benzinga
2 Best Biotech Stocks to Buy Right Now
July 14, 2023
From Motley Fool
From MarketWatch
European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks
July 11, 2023
From Benzinga
From MarketWatch
From Motley Fool
Treasury Yields Spiking As Market Looks Ahead To Jobs Data, Raising Valuation Concerns
July 06, 2023
From Benzinga
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.